Earnings Call Summary | Staar Surgical(STAA.US) Q1 2024 Earnings Conference

The following is a summary of the STAAR Surgical Company (STAA) Q1 2024 Earnings Call Transcript:Financial Performance:STAAR Surgical posted Q1 2024 net sales of $77.4 million, exceeding estimates due

Futu News19minutes ago · Conference Call

Staar Surgical Is Maintained at Buy by Mizuho

Staar Surgical Is Maintained at Buy by Mizuho

Dow Jones20:16

Staar Surgical Price Target Raised to $55.00/Share From $53.00 by Mizuho

Staar Surgical Price Target Raised to $55.00/Share From $53.00 by Mizuho

Dow Jones20:16

Mizuho Bank: Maintaining the Staar Surgical (STAA.US) rating, adjusted from buy to buy rating, and adjusted the target price from $53.00 to $55.00.

Mizuho Bank: Maintaining the Staar Surgical (STAA.US) rating, adjusted from buy to buy rating, and adjusted the target price from $53.00 to $55.00.

Zhitong Finance20:10

Mizuho Maintains Buy on Staar Surgical, Raises Price Target to $55

Mizuho analyst Anthony Petrone maintains Staar Surgical with a Buy and raises the price target from $53 to $55.

Analyst Upgrades20:06

Staar Surgical Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 22.22% Mizuho $53 → $55 Maintains Buy 04/11/2024 17.78% Mizuho $45 → $53 Maintains Buy 04/08/20

Benzinga20:05